<DOC>
	<DOCNO>NCT00562887</DOCNO>
	<brief_summary>To compare efficacy , safety pharmacokinetics ABT-874 placebo subject moderately severely active Crohn 's Disease .</brief_summary>
	<brief_title>Dose Ranging Study Comparing Efficacy , Safety Pharmacokinetics Intravenous Infusions ABT-874 v Placebo Subjects With Active Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Diagnosis Crohn 's disease great 4 month confirm endoscopy radiologic evaluation . CDAI score &gt; = 220 &lt; = 450 Week 0 . Males females &gt; = 18 year &lt; 75 year age Screening visit . Judged generally good health determine Investigator . Current diagnosis colitis Crohn 's disease . Symptomatic known stricture . Surgical bowel resection within past 6 month plan resection time point enrol study . Ostomy ileoanal pouch . ( Subjects previous ileorectal anastomosis exclude ) . Short bowel syndrome determine investigator . Infection risk factor severe infection . Females pregnant consider become pregnant study , breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Crohn 's Disease</keyword>
</DOC>